United States · Platforms & data · Barchart

UPDATE -- Alamar Biosciences and Nightingale Health to Lead UK Biobank 80,000-Sample Neurodegenerative Disease Study

Published by Barchart · United States 3 h ago

Read the full article on Barchart Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (news.google.com)

Also worth reading

IperionX Targets Defense Orders as Virginia Titanium Powder Plant Ramps Up

Palantir forecasts Q4 revenue of $2.649B-$2.653B as it raises 2026 revenue guidance to $8.530B-$8.534B

The Motley Fool

Why Amplitude Stock Jumped 23% in October

Disney moves toward thousands of job cuts, Bloomberg reports

Here’s why Palantir’s stock is down despite a ‘bombastic’ quarter

Stock market after midterm elections: What S&P 500 history shows